Percutaneous Treatment of Claudication: The Role of Diabetes and Inflammation
经皮跛行治疗:糖尿病和炎症的作用
基本信息
- 批准号:7652478
- 负责人:
- 金额:$ 15.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptionAdvisory CommitteesAffectAftercareAmericanAnatomyAngioplastyAnkleArterial Occlusive DiseasesArteriesAttentionBiologicalBiological MarkersBlood VesselsCD40 LigandCardiovascular DiseasesCardiovascular systemCaringCentral obesityCharacteristicsClinicalClinical ResearchCohort StudiesComplement 2ComplexCost AnalysisDataDatabasesDiabetes MellitusDiseaseDisease ProgressionDistalEconomicsEducational process of instructingEffectivenessEventFactor AnalysisFailureFibrinolysisGeneral PopulationGlycosylated HemoglobinGrantHealthHealth Services ResearchHigh Density Lipoprotein CholesterolHospitalsHypertensionHypertriglyceridemiaImpairmentIndividualInferiorInflammationInflammatory ResponseInstitutionInsulinInsulin ResistanceInterleukin-6Intermittent ClaudicationInterventionIschemiaLesionLimb structureLipidsLower ExtremityMaintenanceMeasuresMedicalMedicineMetabolic syndromeMorbidity - disease rateNeuropathyObesityOperative Surgical ProceduresOutcomePathway interactionsPatient CarePatientsPatternPerformancePeripheralPeripheral arterial diseasePhysiologic pulsePlasminogen Activator Inhibitor 1Predictive ValuePrincipal InvestigatorProceduresProcessPublic HealthPublic Health SchoolsQuality of lifeQuestionnairesRegression AnalysisRehabilitation therapyResearchResearch PersonnelResourcesRiskRisk FactorsRoleScanningSurveysSystemTechniquesTestingTrainingTreadmill TestsTreatment FailureTreatment outcomeUniversitiesVisitWalkingWomanabstractingbasecardiovascular risk factorcareer developmentclaudicationcofactorcopingcostdiabeticdisorder riskexperiencefasting glucosefollow-upfunctional outcomesglucose metabolismglycemic controlhemodynamicsimpaired glucose toleranceimproved functioningindexinginflammatory markerinstructorlipid disordermedical schoolsmortalitypatient populationprogramsprospectiveresponserestenosisrisk benefit ratiosuccesstrend
项目摘要
DESCRIPTION (provided by applicant):
Diabetes (DM) and peripheral artery disease (PAD) are rapidly growing health concerns among
Americans. In particular, intermittent claudicatiori (IC) affects walking function, general quality of life (QOL), and can herald worsening ischemia. The use of arterial angioplasty and stenting to treat lower extremity arterial occlusive disease has increased recently. However, clinical outcomes have been mixed and their impact on patient QOL difficult to measure, especially for patients with DM who may have additional biological and functional obstacles to treatment success. Louis Nguyen, MD, MBA, is Instructor of Surgery in the Division of Vascular & Endovascular Surgery and Investigator in the Center for Surgery and Public Health at Brigham & Women's Hospital (BWH), a teaching affiliate of Harvard Medical School. This proposal details a plan to develop Dr. Nguyen into an independent clinical researcher. Because of his unique training and experience in surgery and health services research,
Dr. Nguyen intends to study problems in vascular surgery by using a combination of institutionally-based clinical studies with nationally collected databases. The plan proposed in this grant will capitalize on the educational, research, and career development resources of several Harvard University institutions. Drs. Michael Conte (Vascular Surgery), John Ayanian (Medicine and Harvard School of Public Health [HSPH]), and Mark Creager (Cardiovascular Medicine) will comprise the Advisory Committee. Drs. Allison Goldfine (Joslin Diabetes Center) and Myriam Hunink (HSPH) will serve as consultants. All five are internationally recognized clinician-researchers in their fields. The proposed prospective observational cohort study will examine the effects of DM, insulin resistance, and inflammation on outcomes of infrainguinal percutaneous peripheral interventions for IC. The first aim examines hemodynamic outcomes using arterial duplex. The second aim examines functional outcomes using treadmill walking performance and QOL surveys. The third aim combines these findings to examine larger treatment implications with a cost analysis and CMS database analysis specific to the care of DM patients. It is anticipated that this research will contribute to the better clinical and economic understanding of IC treatment outcomes for DM patients with PAD risk factors.
(End of Abstract)
描述(由申请人提供):
糖尿病(DM)和外周动脉疾病(PAD)是人们日益关注的健康问题
美国人。尤其是,间歇性跛行(IC)影响行走功能和一般生活质量(QOL),并可预示缺血恶化。近年来,动脉血管成形术和支架置入术在治疗下肢动脉闭塞性疾病中的应用日益增多。然而,临床结果好坏参半,其对患者生活质量的影响很难衡量,特别是对糖尿病患者来说,他们可能会有额外的生物学和功能障碍来获得治疗成功。Louis Nguyen,医学博士,工商管理硕士,哈佛医学院附属布里格姆妇女医院(BWH)血管和内血管外科的外科讲师和外科和公共卫生中心的研究员。这项提案详细说明了一项将阮博士培养成一名独立临床研究人员的计划。由于他在外科和卫生服务研究方面的独特培训和经验,
阮博士打算结合机构的临床研究和国家收集的数据库来研究血管外科中的问题。这项赠款中提出的计划将利用几个哈佛大学机构的教育、研究和职业发展资源。迈克尔·孔特博士(血管外科)、约翰·阿亚尼安博士(医学和哈佛大学公共卫生学院[HSPH])和马克·克里格博士(心血管内科)将组成咨询委员会。乔斯林糖尿病中心的Allison Goldfine博士和HSPH的Myriam Hunink博士将担任顾问。这五人都是各自领域的国际公认的临床医生和研究人员。这项拟议的前瞻性观察队列研究将检验糖尿病、胰岛素抵抗和炎症对腹股沟下经皮外周介入治疗IC结果的影响。第一个目标是使用动脉双功检查血流动力学结果。第二个目的是通过跑步机行走能力和生活质量调查来检查功能结果。第三个目标是将这些发现与成本分析和专门针对糖尿病患者护理的CMS数据库分析结合起来,以检查更大的治疗影响。预计这项研究将有助于更好地了解存在PAD危险因素的糖尿病患者的IC治疗结果。
(摘要结束)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louis Loc Nguyen其他文献
Louis Loc Nguyen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Louis Loc Nguyen', 18)}}的其他基金
Percutaneous Treatment of Claudication: The Role of Diabetes and Inflammation
经皮跛行治疗:糖尿病和炎症的作用
- 批准号:
7485722 - 财政年份:2006
- 资助金额:
$ 15.93万 - 项目类别:
Percutaneous Treatment of Claudication: The Role of Diabetes and Inflammation
经皮跛行治疗:糖尿病和炎症的作用
- 批准号:
7883331 - 财政年份:2006
- 资助金额:
$ 15.93万 - 项目类别:
Percutaneous Treatment of Claudication: Role of Diabetes
经皮跛行治疗:糖尿病的作用
- 批准号:
7085996 - 财政年份:2006
- 资助金额:
$ 15.93万 - 项目类别:
Percutaneous Treatment of Claudication: The Role of Diabetes and Inflammation
经皮跛行治疗:糖尿病和炎症的作用
- 批准号:
7267828 - 财政年份:2006
- 资助金额:
$ 15.93万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.93万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
Standard Grant














{{item.name}}会员




